Valera Health

Valera Health

Signal active

Organization

Contact Information

Overview

Founded in 2015, Valera Health combines digital technology and data science with a human touch to deliver in-class clinical services to patients with mild to severe mental health conditions including depression to schizophrenia. With a focus on outcomes and servicing hard-to-reach populations, Valera Health is redefining high-performing mental healthcare.

About

Industries

Health Care, Wellness, mHealth, Mental Health

Founded

2015

Employees

251-500

Headquarters locations

New York, United States, North America

Social

N/A

Profile Resume

Valera Health headquartered in New York, United States, North America, operates in the Health Care, Wellness, mHealth, Mental Health sector. The company focuses on Health Care and has secured $9.2B in funding across 128 round(s). With a team of 251-500 employees, Valera Health is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Valera Health, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Prashant Gharpure

Prashant Gharpure

Chief Technology Officer

imagePlace Thomas Tsang

Thomas Tsang

CEO, Co-Founder

imagePlace Ofer Sharon

Ofer Sharon

President, Co Founder

Funding Rounds

Funding rounds

8

Investors

1

Lead Investors

0

Total Funding Amount

$71.9M

Details

3

Valera Health has raised a total of $71.9M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2017Early Stage Venture3.4M
2020Early Stage Venture
2015Seed

Investors

Valera Health is funded by 42 investors.

Investor NameLead InvestorFunding RoundPartners
Valera Health-FUNDING ROUND - Valera Health45.0M
Figure 8 Investments-FUNDING ROUND - Figure 8 Investments45.0M
Valera Health-FUNDING ROUND - Valera Healthundefined
StartUp Health-FUNDING ROUND - StartUp Healthundefined

Recent Activity

There is no recent news or activity for this profile.